Tetrodocain

Tetrodocain is a North Korean medical injection produced by the Korea Jangsaeng Joint Venture Company, first claimed to have been invented in 2004. Its active ingredient is tetrodotoxin extracted from puffer fish poison, and it is presented as an anaesthetic agent. North Korea's state news agency has claimed the drug treats cancer, tuberculosis, chronic hepatitis, pancreatitis, HIV and AIDS, and narcotics addiction, but independent assessment has found these claims to be either exaggerated or false, with documented evidence limited mostly to its anaesthetic action. The product has been marketed for export through websites based in Russia and China, and North Korea released a clinical research thesis on its anaesthetic applications in 2015. Independent verification of its broader therapeutic claims remains lacking.